Depression and anxiety disorders arise from complex disturbances in brain chemical signalling. Key monoamine neurotransmitters—serotonin, noradrenaline and dopamine—regulate mood, motivation and ...
Major depressive disorder is characterised by altered brain structure, connectivity and chemical signalling. Neuroimaging modalities have elucidated structural atrophy in prefrontal and limbic regions ...
In the intricate chemical symphony of the brain, glutamate stands as the principal conductor. As the brain's most abundant excitatory neurotransmitter, glutamate facilitates our ability to learn, form ...
Since the 1960s, researchers have postulated that major depression stems from disruptions in the serotonin neurotransmitter system, but the evidence for that idea, though plentiful, was indirect. In ...
In a study that spanned 15 years, researchers at the University of Florida learned how a receptor called GPR158 functions in relation to depression. In a study of mice that experienced suppression of ...
PsyPost on MSN
Clinical trial suggests an anti-inflammatory drug could relieve difficult-to-treat depression
A recent clinical trial suggests that treating the immune system with an anti-inflammatory drug could relieve symptoms in ...
4monon MSN
Exercise may be as effective as antidepressants in treating depression symptoms, study says
Researchers say exercise may be just as beneficial as medication, but caution that more studies are needed ...
Now, a new study using nationally representative U.S. data found that adults with adequate levels of several key micronutrients (including vitamin D, iron, selenium, copper, and vitamin B6) were less ...
Dextromethorphan, often taken as a cough suppressant, is now approved to treat major depressive disorder (MDD) in combination with bupropion. A clinical trial found that dextromethorphan/bupropion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results